Spineway S.A.
ALSPW.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.74M
Close$
Share Statistics
| Market cap | $3.74 Million |
|---|---|
| Enterprise Value | $2.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.27 |
| Outstanding Shares | 35,507,000 |
Return
| Return on Equity | -18.46% |
|---|---|
| Return on Assets | -14.45% |
| Return on Invested Capital | -2.72% |
Valuation & Multiples
| P/E Ratio | -1.58 |
|---|---|
| PEG | -17.92 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | -3.34 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$5.70 M
Average shareholder expectationNext Earnings Call
Expected Date
January 25, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$5.70 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Spineway S.A.
43 employees
CEO: Stéphane Le Roux Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbo...